GRANIX Drug Profile

« Back to Dashboard

Summary for Tradename: GRANIX

Patents:	0
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for GRANIX

Ingredient-type	Granulocyte Colony-Stimulating Factor Granulocyte-Macrophage Colony-Stimulating Factor
Physiological Effect	Increased Myeloid Cell Production

US Patents for GRANIX

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Sicor Biotech	GRANIX	tbo-filgrastim	INJECTABLE; INJECTION	125294	002	2012-08-29	➤ Sign Up		➤ Sign Up	RX
Sicor Biotech	GRANIX	tbo-filgrastim	INJECTABLE; INJECTION	125294	001	2012-08-29	➤ Sign Up		➤ Sign Up	RX
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.